CONNECTING PEOPLE WITH PARKINSON'S TO FUTURE RESEARCH OPPORTUNITIES
ACCELERATING NEUROLOGICAL BREAKTHROUGHS BY STREAMLINING THE PATHWAY TO CLINICAL TRIALS
OVERVIEW
The Trial Ready Cohort Initiative is designed by the American Neurological Association (ANA) to help researchers identify, educate, and stay connected with patients who are interested in participating in clinical research.
This Initiative is open to all patients at least 21 years of age with Parkinson's disease who have been genetically tested and is intended to include a broad and diverse group of individuals. The Initiative hopes to include individuals from various backgrounds, cultures, and communities. Diversity helps researchers better understand how new treatments and therapies work. This helps lead to better results for more people.
Our mission is to provide information to patients making a straightforward pathway to enroll in clinical trials to accelerate the development of potential new treatments, therapies, and cures.
WHO CAN PARTICIPATE IN THE TRIAL READY COHORT?
Individuals may be eligible to join the initiative if they:
- Are 21 years of age or older
- Have been diagnosed with Parkinson's disease
- Have had genetic testing for Parkinson's disease
HOW DOES THIS PROCESS WORK?
If you appear to be a good candidate, you will be asked to provide consent for your medical data and contact information to be entered into the Trial Ready Cohort Initiative database.
WHAT IS A CLINICAL RESEARCH STUDY?
A clinical research study, or clinical trial, tests new medical treatments, drugs, or devices to determine their safety and effectiveness in humans. Clinical trials provide researchers with a better understanding of diseases and help them evaluate new medical interventions.
The ANA's Trial Ready Cohort Initiative is not a clinical trial or research study, and joining does not guarantee enrollment in a specific study. Instead, it is a way for patients to learn more about research and authorize permission to be contacted about future research opportunities in which they might be eligible to participate.
For more information about clinical research studies, visit the Center for Information and Study on Clinical Research Participation (CISCRP).
If you would like additional information on clinical trials specific to Parkinson's disease, visit any of the following sites.